These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9640768

  • 1. [Superantigens and retroviral infections. Increase of mammary tumorigenicity due to recombination between exogenous and endogenous MMTV viruses].
    Nepomnaschy I, Buggiano V, Goldman A, Deroche A, Bekinschtein P, Berguer P, Piazzon I.
    Medicina (B Aires); 1997; 57(3):327-31. PubMed ID: 9640768
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.
    Bhadra S, Lozano MM, Dudley JP.
    J Virol; 2009 Jan; 83(1):484-8. PubMed ID: 18922863
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 7. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 8. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
    Schirrmacher V, Beutner U, Bucur M, Umansky V, Rocha M, von Hoegen P.
    J Immunol; 1998 Jul 15; 161(2):563-70. PubMed ID: 9670928
    [Abstract] [Full Text] [Related]

  • 9. Differences of milk-transmitted murine mammary tumor virus (MMTV) among mouse strains.
    Sayama K, Takeda Y, Hashimoto H, Kaneko T, Matsuzawa A.
    In Vivo; 1999 Jul 15; 13(2):135-40. PubMed ID: 10363169
    [Abstract] [Full Text] [Related]

  • 10. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
    Nepomnaschy I, Buggiano V, Goldman A, Piazzon I.
    Medicina (B Aires); 1997 Jul 15; 57(2):235-44. PubMed ID: 9532836
    [Abstract] [Full Text] [Related]

  • 11. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 12. Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens.
    Bhadra S, Lozano MM, Payne SM, Dudley JP.
    PLoS Pathog; 2006 Dec 01; 2(12):e128. PubMed ID: 17140288
    [Abstract] [Full Text] [Related]

  • 13. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.
    Golovkina TV, Piazzon I, Nepomnaschy I, Buggiano V, de Olano Vela M, Ross SR.
    J Virol; 1997 May 01; 71(5):3895-903. PubMed ID: 9094666
    [Abstract] [Full Text] [Related]

  • 14. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S, Shakhov AN, Xenarios I, Haga S, Imai S, Acha-Orbea H.
    Eur J Immunol; 1994 Aug 01; 24(8):1757-64. PubMed ID: 8056034
    [Abstract] [Full Text] [Related]

  • 15. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 16. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
    Ross SR, Dzuris JL, Golovkina TV, Clemmons WC, van den Hoogen B.
    Medicina (B Aires); 1997 Mar 15; 57 Suppl 2():34-42. PubMed ID: 9567342
    [Abstract] [Full Text] [Related]

  • 17. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R, Wang H, Bluethmann H, Iglesias A, Wei WZ.
    Cancer Res; 1994 Mar 15; 54(6):1529-35. PubMed ID: 8137259
    [Abstract] [Full Text] [Related]

  • 18. Retrovirus-host interactions. The mouse mammary tumor virus model.
    Acha-Orbea H.
    Medicina (B Aires); 1997 Mar 15; 57 Suppl 2():43-52. PubMed ID: 9567343
    [Abstract] [Full Text] [Related]

  • 19. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
    Buggiano V, Goldman A, Nepomnaschy I, Bekinschtein P, Berguer P, Lombardi G, Deroche A, Francisco MV, Piazzon I.
    Scand J Immunol; 1999 Mar 15; 49(3):269-77. PubMed ID: 10102644
    [Abstract] [Full Text] [Related]

  • 20. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ, Lozano M, Binhazim AA, Dudley JP.
    J Virol; 1998 Jun 15; 72(6):4746-55. PubMed ID: 9573239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.